在COVID-19大流行期间使用抗抑郁药,抗焦虑药和催眠药
Mikael Tiger1, Giulio Castelpietra2,3, Rikke Wesselhoeft4,5,6
1Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Sweden. mikael.tiger@ki.se.
Translational psychiatry
|April 4, 2024
概括
在COVID-19大流行期间,人们开始积抗抑郁药,抗焦虑药和催眠药. 后来,抗抑郁药的使用增加,特别是在年轻人中,而抗焦虑药和催眠药的使用没有显示出与大流行有关的明显变化.
科学领域:
- 心理健康 心理健康
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- COVID-19大流行引起了人们对其对心理健康的影响的担忧.
- 药物使用,包括抗抑郁药,抗焦虑药和催眠药,是心理健康趋势的关键指标.
研究的目的:
- 在宣布COVID-19大流行后,审查抗抑郁药,抗焦虑药和催眠药的使用趋势.
- 分析处方数据并将其与大流行前的模式进行比较.
主要方法:
- 使用大型国家或区域处方数据库进行的研究的系统审查.
- 分析的重点是从2020年3月起的处方率,与大流行前的趋势相比.
- 包括主要来自高收入国家的数据.
主要成果:
- 2020年3月,抗抑郁药,抗焦虑药和催眠药处方的初步增加,可能是由于积.
- 在最初的激增后的几个月里,抗抑郁药处方率的不一致变化.
- 在晚期的流行病阶段观察到抗抑郁药物使用量的一致,小幅增加,特别是在年轻人中.
- 在2020年3月之后,焦虑缓解剂和催眠剂利用率没有明显变化.
- 高收入国家的抗抑郁药使用现有增长趋势使流行病时代的分析变得复杂.
结论:
- 虽然最初的积发生了,但在COVID-19大流行期间,焦虑缓解剂和催眠剂利用的持续,明显的变化并不明显.
- 在晚些时候的流行病阶段,观察到抗抑郁药使用的小但持续增加,特别是在年轻人中.
- 需要进一步研究COVID-19对心理健康和抗抑郁药的长期影响,并将处方与已诊断的精神疾病相关联.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
47
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.1K
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
01:14CNS Depressants: Barbiturates and Benzodiazepines
259
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
259
01:28Depressants
116
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
116
01:23Sedatives and Hypnotics: Overview
358
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
358
01:23Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43